Literatur
-
1 WHO .Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva. WHO, 29 oct to 1 nov. WHO Tech Rep Ser 2001;. www.who.int/cardiovascular_diseases/resources/trs923/en/
-
2
Cilliers A M.
Rheumatic fever and its management.
BMJ.
2006;
333
1153-1156
-
3
Orvidas L J, Slattery M J.
Pediatric autoimmune neuropsychiatric disorders and streptococcal infections: Role of otolaryngologist.
Laryngoscope.
2001;
111
1515-1519
-
4
Dajani A S. et al. (AHA writing group) .
Guidelines for the diagnosis of Rheumatic Fever: Jones Criteria, Updated 1992.
Circulation.
1993;
87
302-307
-
5
Herdy G V, Souza D C, Barros P B, Pinto C A.
Secondary prophylaxis in rheumatic fever. Oral antibiotic therapy versus benzathine penicilline.
Arq Bras Cardiol.
1996;
67
331-333
-
6
Keitzer R.
Akutes rheumatisches Fieber (ARF) und Poststreptokokken reaktive Arthritis (PSRA) - Ein Update.
Z Rheumatol.
2005;
64
295-307
-
7
Mayemba J, Mayosi M B.
Penicillin for secondary prevention of rheumatic fever.
Cochrane Database Syst Rev.
2002;
3
CD002227
Dr. med. Rolf Keitzer
Kinder- und Jugendrheumatologie, Universitätsklinikum Charité - Campus Virchow
Augustenburger Platz 1
13353 Berlin
eMail: Rolf.Keitzer@charite.de
